Ironwood Pharmaceuticals Inc SEC filings IRWD

Ironwood Pharmaceuticals Inc has 1,003 filings in SEC EDGAR's recent list, going back to Nov 4, 2014. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Ironwood Pharmaceuticals Inc SEC filings
Form Description Filed Period
S-8 Employee stock plan registration Nov 5, 2026 —
S-8 Employee stock plan registration Nov 9, 2023 —
S-3ASR Automatic shelf registration Nov 9, 2023 —
S-3ASR Automatic shelf registration Nov 6, 2020 —
S-8 Employee stock plan registration May 31, 2019 —
S-8 Employee stock plan registration May 31, 2019 —
S-8 Employee stock plan registration Aug 6, 2018 —
S-8 Employee stock plan registration Aug 6, 2018 —
S-3ASR Automatic shelf registration Nov 2, 2017 —
S-8 Employee stock plan registration Aug 3, 2017 —
S-8 Employee stock plan registration Aug 3, 2017 —
S-8 Employee stock plan registration Aug 8, 2016 —
S-8 Employee stock plan registration Aug 8, 2016 —
S-8 Employee stock plan registration Aug 7, 2015 —
S-8 Employee stock plan registration Aug 7, 2015 —
S-3ASR Automatic shelf registration Nov 5, 2014 —

Showing 16 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
IRWD (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Boston, MA
SEC filer status
Accelerated filer, Smaller reporting company
SEC CIK
1446847

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.